Pharmaceutical

Drug sales stood at ₹12,078 crore in January, up 7.6% from a year ago. In comparison, sales were up 8.8% in DecemberAnti-diabetic and gastrointestinal drugs were among the therapy areas that dragged sales in the pharmaceutical market

Profit was lower than ₹431.2 crore estimated by a Bloomberg poll of 24 analystsConsolidated revenue from operations stood at ₹4,371 crore, up 9.1% from ₹4,007.54 crore reported a year ago

Domestic industry feels ripple effect of closure of production units in China over environment concerns

A week after withdrawing from the bidding for Pfizer's consumer unit, GlaxoSmithKline agrees to buy Novartis AG's stake in its consumer healthcare joint venture

The deal is the first co-investment by Google and Tencent since the two companies revealed this month that they have signed a patent sharing agreement

We are confident of getting CCI's approval by May without which we cannot sign the global deal, says Bayer's South Asia representative Richard van der Merwe

Issues such as price erosion, competition and delays in getting approvals affecting sales growth continue to plague the pharmaceutical sector in the September quarter

New HIV therapy hits safety, efficacy targets, says another recent study published in the ‘Lancet HIV’

Panacea Biotec signs an agreement with Canada's Apotex to launch Prasugrel 5mg and 10mg tablets, used for the treatment of certain coronary diseases, in the US

Panacea Biotec said its promoters plan to demerge the company's real estate business into a separate firm to be later listed on bourses